Boothbay Fund Management’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-35,787
| Closed | -$802K | – | 1727 |
|
|
2023
Q3 | $802K | Buy |
+35,787
| New | +$802K | 0.02% | 709 |
|
|
2023
Q2 | – | Sell |
-49,885
| Closed | -$2.42M | – | 1942 |
|
|
2023
Q1 | $2.42M | Buy |
+49,885
| New | +$2.42M | 0.05% | 480 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 2227 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 2247 |
|
|
2021
Q4 | – | Sell |
-9,497
| Closed | -$353K | – | 1944 |
|
|
2021
Q3 | $353K | Buy |
9,497
+1,426
| +18% | +$53K | 0.01% | 1040 |
|
|
2021
Q2 | $341K | Buy |
8,071
+1,421
| +21% | +$60K | 0.01% | 1055 |
|
|
2021
Q1 | $315K | Buy |
+6,650
| New | +$315K | 0.01% | 955 |
|
|
2020
Q3 | – | Sell |
-18,000
| Closed | -$913K | – | 1069 |
|
|
2020
Q2 | $913K | Sell |
18,000
-10,000
| -36% | -$507K | 0.06% | 349 |
|
|
2020
Q1 | $1.25M | Buy |
+28,000
| New | +$1.25M | 0.1% | 209 |
|
|
2019
Q2 | – | Sell |
-8,811
| Closed | -$332K | – | 769 |
|
|
2019
Q1 | $332K | Buy |
+8,811
| New | +$332K | 0.03% | 389 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 759 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 795 |
|